Now We Begin

Benign prostatic hyperplasia: now we can begin to tailor treatment.

Our treatment strategies for benign prostatic hyperplasia (BPH) have changed, with new insights into the pathophysiology of the disease, new clinical trials, and surgical advances. We present an update on treatment options and a diagnostic and treatment algorithm for this condition.

Adhesive small bowel obstruction: where do we stand now?

Adhesive small bowel obstruction (ASBO) is one of the most frequently encountered disorders in Emergency Surgery Departments worldwide without negligible hospital admission rates and social costs (1,2). Notwithstanding significant improvements in techniques and materials, intra-abdominal adhesions following abdominal surgery still represent a major unsolved and debated issue harbouring challeng...

The Battle Against COVID-19: Where Do We Stand Now?

We Crashed, Now What?

We present an in-depth analysis of the crash-recovery problem and propose a novel approach to recover from otherwise fatal operating system (OS) crashes. We show how an unconventional, but careful, OS design, aided by automatic compiler-based code instrumentation, offers a practical solution towards the survivability of the entire system. Current results are encouraging and show that our approa...

Now We Are Six

1 Sabin Vaccine Institute and Texas Children’s Hospital Center for Vaccine Development, Departments of Pediatrics and Molecular Virology & Microbiology, Baylor College of Medicine, Houston, Texas, United States of America, 2 National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas, United States of America, 3 James A. Baker III Institute for Public Policy, Rice Universit...